The pharmaceutical industry is rapidly transforming with breakthroughs in biotechnology, artificial intelligence, and advanced drug delivery technologies. Today, innovation is not only about discovering new drugs but also about improving precision, efficiency, and patient outcomes. As research moves toward personalized medicine and smarter healthcare solutions, the direction of the pharma future becomes an exciting discussion.
What do you think will dominate the future of pharma — biologics, AI drug discovery, or smart drug delivery systems?
MBH/PS
2 Likes
The future of pharma is shaped by the integration of the three domains including biologics, AI in drug discovery and smart delivery systems.
AI in drug discovery has a prominent role in pharma industry, as it highlights the importance of personalized medicine systems and smart healthcare solutions. AI has gradually developed the healthcare domain through its application in target Identification, molecular screening and re-purposing of existing drugs.
Additionally, Biologics are equally important as they focus on gene therapies and m-RNA based treatments. It has high specificity and targeted action in rare genetic disorders and rare autoimmune diseases.
Smart delivery systems, on the other hand, are helpful in understanding how the drug affects the body and how effectively the action and bioavailability can be improved through nanoparticle systems and controlled release drug delivery systems.
Therfore, all three domains are involved in the betterment of future pharma and healthcare systems.
1 Like
All three systems are important but AI in drug discovery is slightly dominating as it involves faster drug discovery process . Now it takes around 15 to 20 years for new drug development by using AI it can be done in few months only .
It helps in analyzing huge patient database ,identifying the disease it’s causing factors and suggests new drug therapy . It helps in reducing the expenses by reducing the chances of failure and optimization of drug.
AI Driven technology,